Glad to be working with Dr. D. Martin Alexander Gershon, MD, JD, MPH as a Lead-Mentor-In- Residence at our program and to be able to give our companies access to programs like the one highlighted below that Martin is leading providing vital connections between startups/innovation organizations and leading health and tech institutions across the country.
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman Sachs•McKinsey•Sloan-Kettering Oncologist•FDA Attorney•White House Moonshot CancerX
Join Endeavor and Mount Sinai Health Systems and Mount Sinai Innovation Partners, in collaboration with Goodwin, and participation from leading companies Google Cloud and Google for Startups, Techstars, Nvidia, Intersystems, Insilico Medicine, Memorial Sloan-Kettering Cancer Center, Mass General Brigham Hospital, Northwell Health, Sanofi, Bayer, Abbvie, SUNY Downstate Medical Center, National Institutes of Health, CSSi, PlugNPlay, ATEM Capital, Keiretsu Forum and over 100 remarkable healthtech companies and VC investors for a day of partnering, investment and deal making, designed to deploy and integrate AI into the New York healthcare system. VIRTUAL TICKET https://shorturl.at/GuOgU LIVE TICKET https://shorturl.at/HCUl9 PITCH TICKET for Emerging HealthTech https://shorturl.at/xOvhU Investment into Healthcare AI is evolving at a historically rapid pace. A total of $100B has been invested in healthcare AI by Google, Amazon, Microsoft, Nvidia, and Apple, with $2.8B invested in the first quarter of 2024. But while technology giants support these startups, healthcare providers and emerging companies alike are finding it difficult to navigate the complexities of AI deployment in this critical sector. Endeavor Venture Group and the Mount Sinai Health System are partnering because we believe that the nexus of scientific discoveries, advanced medicine, and cutting-edge AI technology can deliver significant breakthroughs to improve patient care. Our strategic approach involves not only investing in groundbreaking technologies but also fostering collaborations with major corporations across Big Tech, HealthTech, Big Pharma, MedTech, Biotech, and Finance. This synergy is crucial for successful commercialization and scaling disruptive innovations.